Company Announces Update to Phase 3 XPORT-EC-042 Trial of Selinexor as Maintenance Therapy in Advanced or Recurrent TP53 Wild-Type Endometrial ...

Immunotherapy is leading the charge in the advancement of cancer treatment. In addition to increased life expectancy, it ...

The chemical creates trihalomethanes (THMs) that increase the risk of bladder cancer by 33 percent and colorectal cancer by ...

My annual scan showed no cancer recurrence, but revealed some minor issues related to aging and potential fibroids, requiring ...

The Sex and the City star was diagnosed with breast cancer in 2006, and after surgery and radiation treatments, she was given ...

TV star and model Danielle Lloyd has revealed she’s been diagnosed with skin cancer at the age of 41. The former beauty ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

Drs Ursula A. Matulonis and Eloise Chapman-Davis discuss overcoming health disparities in endometrial cancer and increasing clinical trial enrollment of Black women.

Cancer is a devastating disease, and in 2025, a staggering 618,120 people in the United States will lose their lives to it. We all know someone who has been affected — and that’s why awareness ... The ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

Researchers have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.